BRVE SCHEDULE 13G: SEC filing

Travis Murdoch, M.D.

Filed with the SEC on · accession 0001628280-26-074219

BRVE filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

Travis Murdoch, M.D. filed a Schedule 13G reporting beneficial ownership of 8,379,470 shares (9.3%) of Braveheart Bio, Inc. common stock as of September 30, 2026, including shares held directly, through family trusts, and exercisable options.

Key details

Shares beneficially owned$8.4M
Shares outstanding$89.9M
IssuerBraveheart Bio, Inc.
ShareholderMurdoch Family Trust
ShareholderIrrevocable Gift Trust for Alizee
ShareholderIrrevocable Gift Trust for Siena
Reporting person / beneficial ownerTravis Murdoch

✦ Ask GOAX AI about this filing — what it means for BRVE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BRVE?

Click here

Frequently asked questions

What did BRVE file with the SEC on Nov 16, 2026?

BRVE filed a SCHEDULE 13G (SEC filing). Travis Murdoch, M.D. filed a Schedule 13G reporting beneficial ownership of 8,379,470 shares (9.3%) of Braveheart Bio, Inc. common stock as of September 30, 2026, including shares held directly, through family trusts, and exercisable options.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

Other BRVE SEC filings

Get alerts when BRVE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days